Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Eli Lilly, International Federation of Red Cross and Red Crescent Societies infectious news

LLY will contribute $1.6 million to the federation's multi-drug resistant tuberculosis

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE